Verified source report
Trump is backing psychedelic research: here’s why – podcast
Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise in relieving the long term effects of traumatic brain injury. Madeleine Finlay talks to journalist Mattha Busby about podcaster Joe Rogan’s role in the story, what else is behind the President’s interest in psychedelic research, and what the order will change in practice for scientists and researchers ‘Can I have some, please?’: has Trump opened the door to a psychedelic future? Support the Guardian: theguardian.com/sciencepod Continue reading...
What happened
According to The Guardian’s source item, Trump is backing psychedelic research: here’s why – podcast, Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise in relieving the long term effects of traumatic brain injury. Madeleine Finlay talks to journalist Mattha Busby about podcaster Joe Rogan’s role in the story, what else is behind the President’s interest in psychedelic research, and what the order will change in practice for scientists and researchers ‘Can I have some, please?’: has Trump opened the door to a psychedelic future? Support the Guardian: theguardian.com/sciencepod Continue reading…
Context
The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-05-12T04:00:14+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Trump is backing psychedelic research: here’s why – podcast via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
This source-cited VINI report links to the original publisher record. VINI does not republish third-party article bodies without rights clearance. 1 source listed.
Source links
- Trump is backing psychedelic research: here’s why – podcastThe Guardian - 2026-05-12T04:00:14+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.